ChineseInvestors.com has become top financial-information website The company is also advancing its cannabidiol program CIIX offers investors multiple revenue streams, healthy return potential Based in San Gabriel, California, ChineseInvestors.com Inc. (OTCQB: CIIX) offers a proprietary financial-news media and content platform. … Continue reading →

CIIX CEO speaks to attaining profitability in 2020 as company grows revenue Subsidiary CBD Biotech and CBD cosmetics instrumental in driving CIIX’s growth CIIX leadership focusing on cost cutting, maintaining profitability, and increased revenue with high margin product sales ChineseInvestors.com … Continue reading →

Featured on SmallCapVoice.com interview, Warren Wang outlines plans for CIIX subsidiary, CBD Biotech Inc. CBD Biotech one of few players in China’s fast-growing CBD market Company to focus on hemp/CBD-infused cosmetic products ChineseInvestors.com Inc. (OTCQB: CIIX) provides prominent financial information … Continue reading →

ChineseInvestors.com is foremost financial information website for Chinese-speaking investors in U.S. and China CIIX subsidiary was featured in a recent Wall Street Journal report on China’s growing cannabis industry ChineseInvestors.com has highly diversified revenue streams that contribute to consistent, stable … Continue reading →

CIIX CEO Warren Wang and CBD Biotech executives attended 2019 China Industrial Cannabis CBD Industry International Conference At well over one billion people, China’s cannabis industry market potential is four times the size of America’s CEO responds to stock’s fluctuating … Continue reading →

Wall Street Journal analyzes China’s potential as a cannabis global superpower CEO of CIIX subsidiary discusses company’s role as CBD legal marketer in China, United States CIIX CEO says company is a first mover in legal industrial-hemp skin care and … Continue reading →

CIIX anticipates launch of hemp-infused wrinkle cream in China Through subsidiary CBD Biotech, CIIX will focus hemp and CBD products on the blooming Chinese market The company noted impressive sales, revenue growth for Q1 2020, greatly due to success of … Continue reading →

CIIX will diversify revenue streams to investor relations, marketing/sales of hemp-infused/CBD products in China and the United States Company plans launch of hemp-infused wrinkle cream in China, entering potential market of nearly 1.4 billion people In Q1 FY2020, CIIX sales … Continue reading →

CIIX has carved out unique niche in Chinese-speaking markets, is applying similar business model to rapidly growing CBD industry Focused on China’s emerging industrial hemp and CBD market, which is predicted to reach over $20 billion by 2022 Meeting with … Continue reading →

In MoneyTV interview, CEO Warren Wang notes company’s focus on increasing core investor relations and public relations businesses Investor relations, public relations segment a significant revenue driver for CIIX CIIX 10-K SEC filing reports revenue surge for the three months … Continue reading →